PO.MCB08.05 · 分子与细胞生物学

一种经优化的、基于磁珠的双核酸提取方法的开发与验证,用于对稀缺FFPE肿瘤标本进行高产量基因组分析

Development and validation of an optimized, bead-based dual nucleic acid extraction method for high-yield genomic profiling of scarce FFPE tumor specimens

编号 7269 展板 9 时间 4/22 09:00–12:00 区域 Section 21 主讲 Nripesh Prasad, BS;MS;PhD
分会场 Genomic Approaches to Define Tumor Biology and Clinical Stratification
该海报暂无可下载的资料 AACR 官方页面

作者与单位 Authors & Affiliations

Nripesh Prasad, Rebecca Beatty, Rachel Marshall, Chan-Ho Lee, Elizabeth Coffey, Annamaria Szanto

Discovery Life Science, Huntsville, AL

摘要 Abstract

中文摘要
福尔马林固定石蜡包埋(FFPE)肿瘤组织对回顾性肿瘤学研究至关重要,但从这些样本中——尤其是稀缺的空芯针活检(CNB)——回收高质量核酸(NA)因化学交联、片段化和低投入量而面临挑战,常常影响二代测序(NGS)的成功。为满足从有限FFPE材料进行可靠NGS的需求,我们开发并验证了一种改良的专有双提取方法,专门针对低投入量和高度降解的FFPE组织(包括CNB)进行优化。这种新型的基于磁珠的化学方法采用无二甲苯脱蜡步骤,随后进行Covaris超声处理,以实现优化的裂解和去交联条件。该方法专注于优化关键技术参数,即裂解缓冲液浓度和去交联时间/温度,并与我们的内部标准以及一种商品化的基于柱的标准(Qiagen AllPrep FFPE Dual Kit)进行了基准比较。我们测试了多种肿瘤类型(肾、头颈、膀胱、肺)和不同组织投入量(0.5 mm³至4.0 mm³)的FFPE样本,包括一组已知低质量(LowQ)的FFPE样本。我们评估了三种方法的DNA/RNA产量、完整性(DIN/RIN)和可重复性。改良方法表现出显著优越的性能:DNA产量与回收:该方案使可用DNA产量大幅增加,98.83%的样本达到了最低100 ng的NGS阈值,而使用商品化试剂盒时仅为73.50%。DNA质量:改良方法在不损害DNA完整性的前提下实现了更高的DNA产量,并显著改善了具有挑战性的LowQ FFPE标本的质量指标。RNA质量:RNA完整性也较AllPrep试剂盒显著改善,提升了所得RNA用于RNA测序(RNA-seq)工作流程等复杂下游应用的适用性。该方案表现出高度可重复性,操作者间和批次间变异极小。这种改良双提取方法利用优化的基于磁珠的化学方法和超声处理,能够从最具挑战性的FFPE肿瘤标本中实现优越、高质量且可重复的核酸回收。其相较于传统方案经过验证的性能,对于利用存档或有限组织标本推进癌症研究和精准肿瘤学中的可靠基因组分析至关重要。
查看英文原文 English abstract
Formalin-fixed, paraffin-embedded (FFPE) tumor tissues are crucial for retrospective oncology studies, but recovering high-quality nucleic acids (NA) from these samples-especially scarce core needle biopsies (CNBs)-is challenged by chemical crosslinking, fragmentation, and low input volume, often compromising next-generation sequencing (NGS) success. To meet the demand for reliable NGS from limited FFPE material, we developed and validated a Modified Proprietary Dual Extraction Method specifically optimized for low-input and highly degraded FFPE tissues, including CNBs. This novel, bead-based chemistry utilizes a Xylene-free deparaffinization step, followed by Covaris UltraSonication to achieve optimized lysis and de-crosslinking conditions. The method focused on refining key technical parameters, namely lysis buffer concentration and de-crosslinking time/temperature, and was benchmarked against our Internal Standard and a commercial column-based standard (Qiagen AllPrep FFPE Dual Kit). FFPE samples across multiple tumor types (kidney, head and neck, bladder, lung) and varying tissue inputs (0.5 mm³ to 4.0 mm³) were tested, including a cohort of known low-quality (LowQ) FFPE samples. We evaluated DNA/RNA yield, integrity (DIN/RIN), and reproducibility across all three methods. The Modified Method demonstrated significantly superior performance: DNA Yield and Recovery: The protocol delivered a dramatic increase in usable DNA yield, with 98.83% of samples meeting the minimum 100 ng NGS threshold, compared to only 73.50% using the commercial kit. DNA Quality: The Modified Method achieved higher DNA yields without compromising DNA integrity and notably improved the quality metrics of challenging LowQ FFPE specimens. RNA Quality: RNA integrity also significantly improved over the AllPrep Kit, enhancing the suitability of the resulting RNA for complex downstream applications like RNA sequencing (RNA-seq) workflows. The protocol exhibited high reproducibility with minimal operator or lot-to-lot variability. This Modified Dual Extraction Method, leveraging optimized bead-based chemistry and sonication, enables superior, high-quality, and reproducible recovery of nucleic acids from the most challenging FFPE tumor specimens. Its validated performance over conventional protocols is critical for advancing reliable genomic profiling in cancer research and precision oncology using archived or limited tissue specimens.
利益披露 Disclosure
N. Prasad, None.. R. Beatty, None.. R. Marshall, None.. C. Lee, None.. E. Coffey, None.. A. Szanto, None.

← 返回 AACR 2026 检索